Vote Scores
Filings read through

Roivant Sciences Ltd.: how funds voted at the meeting of 10 Sep 2025

Ticker
ROIV
Meeting
Season
year to 30 June 2026
Filers reporting
411
Ballot items
3

411 filers on Form N-PX reported votes at the Roivant Sciences Ltd. meeting of 10 Sep 2025. The records fall into 3 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    3 nominees. 58.3% of the reported votes are for. 67 filers withheld from or voted against at least one nominee.

    837 vote records from 128 filers. 49 of the 127 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 36 fund families
    • For 22
    • Abstain or withhold 14
    • Against management 14
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    658 vote records from 410 filers. 270 of the 385 filers that marked the item voted against management. 25 filers gave no management mark.

    • Positions of 44 fund families
    • For 7
    • Against 37
    • Against management 37
  3. Item 3: Audit-related items (auditor ratification)

    279 vote records from 128 filers. 3 of the 127 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 36 fund families
    • For 36

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Roivant Sciences Ltd., meeting of 10 Sep 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor
AllianceBernsteinAgainst, against managementNo report
AllspringAgainst, against managementNo report
American CenturyAgainst, against managementFor
BlackRock and iSharesAgainst, against managementFor
BNY MellonAgainst, against managementFor
Brighthouse FundsForFor
Charles SchwabAgainst, against managementFor
Columbia ThreadneedleAgainst, against managementFor
DimensionalAgainst, against managementFor
EquitableForFor
Federated HermesAgainst, against managementFor
FidelityAgainst, against managementFor
First TrustAgainst, against managementNo report
Franklin TempletonAgainst, against managementFor
Goldman SachsForFor
Guggenheim and RydexAgainst, against managementFor
InvescoAgainst, against managementFor
J.P. MorganAgainst, against managementFor
Jackson National fundsAgainst, against managementFor
Janus HendersonAgainst, against managementNo report
John Hancock and ManulifeAgainst, against managementFor
Lincoln FinancialAgainst, against managementFor
Macquarie and Delaware FundsAgainst, against managementFor
MassMutualAgainst, against managementFor
Morgan Stanley, Eaton Vance and CalvertForFor
NationwideAgainst, against managementFor
Natixis and Loomis SaylesAgainst, against managementNo report
Neuberger BermanAgainst, against managementNo report
Northern Trust and FlexSharesAgainst, against managementFor
Nuveen and TIAAForFor
Pacific Life fundsAgainst, against managementFor
PGIM and PrudentialForFor
PrincipalAgainst, against managementFor
ProShares and ProFundsAgainst, against managementFor
Russell InvestmentsAgainst, against managementNo report
SEIAgainst, against managementFor
State Street and SPDRAgainst, against managementFor
T. Rowe PriceAgainst, against managementFor
ThriventAgainst, against managementFor
TransamericaForFor
VanguardAgainst, against managementFor
Victory CapitalAgainst, against managementNo report
VoyaAgainst, against managementFor
WisdomTreeAgainst, against managementFor

Questions

How many filers reported votes at the Roivant Sciences Ltd. meeting?
411 Form N-PX filers reported votes at the meeting of 10 Sep 2025. On say-on-pay, 270 of 385 filers that marked the item voted against management (70.1%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Roivant Sciences Ltd. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Roivant Sciences Ltd. with a meeting date within three days of 10 Sep 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .